
    
      The purpose of this study is to determine whether chemotherapy combination with local
      radiotherapy and recombined human granulocyte-macrophage colony stimulating factor(rhGM-CSF)
      is safe, effective in the treatment of oligometastatic stage IV NSCLC patients who were PR or
      SD after first-line chemotherapyï¼Œand to observe the abscopal effect, whether the scheme can
      improve PFS and OS.
    
  